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S
hunt nephritis is a rare complication mostly
described in the setting of chronic infection of
ventriculoatrial (VA) shunts inserted for the treatment
of congenital or acquired hydrocephalus.1,2 The diag-
nosis of shunt nephritis is challenging and may be
overlooked. We report a case of successfully treated
shunt nephritis and pyogenic spondylitis with positive
antiproteinase 3 antineutrophil cytoplasmic antibody
(PR3-ANCA) in a patient who presented with acute
kidney injury.
CASE PRESENTATION
A 56-year-old Japanese man presented with hematuria,
proteinuria, progressive kidney dysfunction, and a
persistent low grade fever for 4 months. The patient also
had mild spontaneous lower back pain. He had a medical
history of alcoholic liver cirrhosis and secondary
hydrocephalus due to non-HIV cryptococcal meningitis
at the age of 50, initially treated by a ventriculoper-
itoneal shunt. The shunt was subsequently replaced
with a VA shunt because of an intra-abdominal abscess.
On physical examination, his vital signs revealed a
temperature of 37.2 C, a pulse of 71/min with regular
rhythm, and a blood pressure of 115/77 mm Hg. No
abnormalities were detected in the patient’s lungs,
heart, abdomen, or extremities.
Laboratory data revealed an elevated creatinine
(2.35 mg/dl, baseline 0.86 mg/dl; 5 months before
admission), anemia (hemoglobin 9.8 g/dl), mild eleva-
tion of liver enzymes (L-aspartate aminotransferase
67 U/l, alanine aminotransferase 46 U/l), lowcomplement (complement component 3 66 mg/dl, 50%
hemolytic unit of component 28 U/ml), elevated
C-reactive protein (4.33 mg/dl), and positive
PR3-ANCA (67.4 U/ml; reference range <3.5 U/ml).
Urinalysis showed proteinuria (1.63 g/gCr) and hema-
turia (>100 erythrocytes/high power field), both new
findings. Blood culture and cerebrospinal fluid culture
were positive for oxacillin-resistant Staphylococcus
capitis (Table 1). Transthoracic echocardiography
showed no vegetation. Transesophageal echocardiog-
raphy was not performed, because infectious endo-
carditis was not high in our differential diagnosis.
There was increased uptake in the lumbar spine L3-L4
disc on gallium scintigraphy. Lumbar-spine plain
magnetic resonance imaging findings were consistent
with pyogenic spondylitis.
We suspected a VA shunt infection with pyogenic
spondylitis. The VA shunt was removed and antimi-
crobial therapy was immediately started (Figure 1). The
VA shunt was not cultured. Initially, based on the
guideline,3 i.v. vancomycin (0.5–1.0 g/d determined
by the daily trough value) was given for 25 days until
the patient developed a drug eruption. We then
switched to a combination of minocycline (200 mg/d)
and clindamycin (1800 mg/d). We continued parenteral
antibiotics for a total of 9 weeks. Blood cultures turned
negative on day 10 of antibiotic treatment. During the
antibiotic therapy, his proteinuria and hematuria
resolved, and renal function returned to his baseline.
Complement and C-reactive protein normalized over the
treatment course (Figure 1). His lower back pain also
improved. Symptoms of hydrocephalus remained absent
even without a VA shunt. There were no signs orKidney International Reports (2017) 2, 774–778
Table 1. Laboratory findings on admission
Hematology Reference range Serology Reference range Urinalysis Reference range
WBC 6600/ml 4500–9000 IgG 3398a mg/dl 870–1700 pH 5.0 5.0–7.0
Neutrophils 73.6% IgG4 21a mg/dl 48–105 RBC >100a/HPF (dysmorphic) <5
Lymphocytes 16.5% IgA 344 mg/dl 110–410 WBC 20–29a/HPF <5
Eosinophils 0.3% IgM 305a mg/dl 33–190 Hyaline cast 0–1/LPF
Hb 9.8a g/dl 14.0–17.0 IgE 35.7 mg/dl <170 Granular cast 1–2a/LPF <1
Plt 179  103/ml 150–350  103 C3 66 mg/dl 65–135 b2MG 189.7 mg/l <360
Biochemistry C4 18 mg/dl 13–35 NAG 10.7 U/l <11.2
TP 8.1 g/dl 6.5–8.2 CH50 28a U/ml 32–49 U-pro/U-Cr 1.63 g/gCr <0.15
Alb 2.5a g/dl 3.9–4.9 RF <10 U/ml <15 CSF
BUN 38a mg/dl 8–20 Cryoglobulin (–) (–) Cells 1/ml 0–5
Cr 2.35a mg/dl 0.5–1.1 ANA 80a <40 Protein 16 mg/dl 14–45
Na 136 mEq/l 135–146 MPO-ANCA <1.0 U/ml <3.5 Glucose 55 mg/dl 50–75
K 4.9a mEq/l 3.5–4.8 PR3-ANCA 67.4a IU/ml <3.5
Ca 8.6a mg/dl 8.8–10.1 Anti-GBM Ab <2.0 U/ml <3.0
UA 7.3a mg/dl 3.0–7.0 HBs-Ag (–) (–) CSF culture
AST 67a U/l 10–35 HCV-Ab (–) (–) Positive for Staphylococcus capitis
ALT 46a U/l 5–40 HIV Ag/Ab (–) (–) Blood culture
CK 26a U/l 40–200 STS/TPHA (–) (–) Positive for Staphylococcus capitis
T-Bil 0.6 mg/dl 0–1.0 T-SPOT (–) (–)
T-Cho 142 mg/dl 130–220 1,3-b-D-glucan <6.0 pg/ml (–)
HDL-C 35a mg/dl 40–100
TG 100 mg/dl 35–150
HbA1c 5.8% 4.6–6.2
Ferritin 296a ng/ml 21–275
CRP 4.33a mg/dl <0.3
Ab, antibody; Ag, antigen; Alb, albumin; ALT, alanine aminotransferase; ANA, antinuclear antibody; ANCA, antineutrophil cytoplasmic antibody; AST, L-aspartate aminotransferase;
b2MG, beta 2 microglobulin; BUN, blood urea nitrogen; C3, complement component 3; C4, complement component 4; Ca, calcium; CH50, 50% hemolytic unit of component; CK, creatine
kinase; Cr, creatinine; CRP, C-reactive protein; CSF, cerebrospinal fluid; GBM, glomerular basement membrane; Hb, hemoglobin; HBs, hepatitis B surface; HCV, hepatitis C virus; HDL-C,
high-density lipoprotein cholesterol; HIV, human immunodeficiency virus; HPF, high power field; K, potassium; LPF, low power field; MPO, myeloperoxidase; Na, sodium; NAG, N-acetyl-
beta-D-glucosaminidase; Plt, platelet; PR3, proteinase 3; RBC, red blood cell; RF, rheumatoid factor; STS, serologic test for syphilis; T-Bil, total bilirubin; T-Cho, total cholesterol; T-SPOT, a
type of enzyme-linked immunospot assay used for tuberculosis diagnosis, which belongs to the group of interferon-gamma release assays; TG, triglyceride; TP, total protein; TPHA,
treponema pallidum latex agglutination; U-pro/U-Cr, urinary protein-creatinine ratio; UA, uric acid; WBC, white blood cell.
aValues that are out of normal range.
H Ono et al.: Shunt Nephritis With Positive PR3-ANCA NEPHROLOGY ROUNDSsymptoms of granulomatosis with polyangiitis (Wege-
ner’s granulomatosis), although serum levels of PR3-
ANCA did not decrease. After 5 months from the
beginning of treatment, titers for PR3-ANCA remain
high (85.1 U/ml).
DISCUSSION
Shunt nephritis, an infection-related glomerulone-
phritis, is a dreaded complication of a VA shunt.
Although the incidence of VA shunt infection is rela-
tively high, approximately 12%, only 0.7% to 2.3% of
infected patients develop shunt nephritis.2 Therefore,
its diagnosis is sometimes difficult and often delayed or
missed. Although 160 cases have been reported in the
literature,4,5 the number of patients with shunt
nephritis is decreasing because VA shunts are being
replaced with ventriculoperitoneal shunts.6
There have been some recent reports about immune-
complex-mediated glomerulonephritis related to
infections of long-term central venous catheter usage,
often placed for extensive cancer chemotherapy treat-
ment.6,7 Cases of shunt nephritis may increase because
of the increased usage of these indwelling centralKidney International Reports (2017) 2, 774–778venous catheters. Physicians should be aware of the
diagnosis and management of this condition.
Kidney biopsy often suggests a diagnosis of shunt
nephritis. A typical kidney biopsy of shunt nephritis
shows membranoproliferative glomerulonephritis with
immune-complex deposition.5 In this case, we did not
perform a kidney biopsy because of the presence of
persistent bacteremia and prioritization of shunt
removal by the neurosurgeons. In this case, the clinical
improvement with antibiotics, resolution of proteinuria
and hematuria, and improvement of renal function
strongly support the diagnosis of shunt nephritis.
It is unclear how long antibiotics should be used for
this situation. In this case, we followed the recom-
mended antibiotic treatment period for pyogenic
spondylitis. A total duration of 6 weeks of parenteral or
highly bioavailable oral antimicrobial therapy is rec-
ommended.3 In another literature review, criteria for
discontinuation of antimicrobial treatment include
symptom resolution or improvement and the normali-
zation of erythrocyte sedimentation rate or C-reactive
protein.8 Considering this information, the period of





















































Hematuria (RBC/HPF)               >100    >100   
U-pro/U-Cr (g/gCr)                      1.63     0.67    0.86       0.41     0.09      0.05      0.13     0.06       0.04     0.08
-6 -4 -1 0 1 2         3          5    month
-6 -4 -1 0 1 2         3            5    month
50–99 30–49 10–19 1–4 1–4 5–9 10–19 1–4
Figure 1. Clinical course. ANCA, antineutrophil cytoplasmic antibody; CH50, 50% hemolytic unit of component; CRP, C-reactive protein;
HPF, high power field; PR3, proteinase 3; RBC, red blood cell; sCr, serum creatinine; U-pro/U-Cr, urinary protein-creatinine ratio.
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used antibiotics for a total of 9 weeks, while monitoring
the urinalysis and C-reactive protein. After treatment
his lower back pain improved and there has been no
recurrence of nephritis and spondylitis.
Coagulase-negative staphylococci, especially Staphy-
lococcus epidermidis, are the most common cause of
foreign body infections, including shunt nephritis.
S. capitis was the cause of nephritis in our case. It is
generally considered a nonpathogenic bacterium and is
rarely associated with foreign body infections.9
Cryptococcosis is an opportunistic infection that
defines AIDS in HIVþ patients but is also seen in other
immunocompromised situations. Our patient was
previously diagnosed with cryptococcal meningitis
despite the negative HIV infection. Although there
was no decrease in CD4 nor impaired humoral
response, it is still possible that this patient has im-
mune deficiency related to chronic liver cirrhosis that
might have allowed this nonpathogenic attenuated
bacterium to cause the persistent bacteremia and
nephritis.776ANCAs were originally described in 1982,10 and the
PR3 antigen was discovered in 1989.11 PR3-ANCA usu-
ally causes a C-ANCA pattern and is well known as a
specific marker of granulomatosis with polyangiitis.
Testing for PR3-ANCA by using an indirect immuno-
fluorescence technique or enzyme-linked immunosor-
bent assay has very high specificity (95%–100%) and
high sensitivity (61.8%–97.1%).12 Although
PR3-ANCA testing is a useful clinical tool in daily
practice, it is still considered controversial because
ANCA becomes positive under conditions other than
vasculitis (e.g., infections or exposure to drugs). In
these cases, the patient’s condition might be worsened
by immunosuppression.12 ANCA formation has been
reported in the course of various chronic viral (e.g.,HIV,
Hepatitis B, Hepatitis C), bacterial (e.g., Streptococcus,
Staphylococcus, Enterococcus), fungal (e.g., Aspergillus),
protozoal (e.g., Streptococcus, Staphylococcus, Entero-
coccus), and multicellular parasitic infection (e.g., Echi-
nococcus).13 For example, PR3-ANCA in infectious
endocarditis is a typical disease.14,15 In shunt nephritis,
PR3-ANCA could also become positive. ThreeKidney International Reports (2017) 2, 774–778
Table 2. Shunt nephritis with positive PR3-ANCA in published case reports and our patients
Case Bonarek et al.16 Nagashima et al.17 Iwata et al.18 Our patient
Age, sex 50, F 17, F 55, M 56, M
Cause of hydrocephalus Arachnoid cyst Congenital hydrocephalus Brain abscess Secondary hydrocephalus
Shunt Cyst-atrial VA VA VA
Causal organism Propionibacterium acnes Gemella morbillorum Propionibacterium acnes Staphylococcus capitis
Duration of shunt (yr) 9 10 7 2
Serum creatinine 1.4 mg/dl 1.1 mg/dl 1.5 mg/dl 2.35 mg/dl
Urinary protein 3.5 g/d 1.4 g/d 5.4 g/d 1.63 g/gCr
C3 (reference range, 65–135 mg/dl) 55 39.9 39.9 66
C4 (reference range, 13–35 mg/dl) 16 3 10.3 18
CH50 (reference range, 32–49 U/ml) Undetectable <8 <5 28
PR3-ANCA (before therapy) 1/500 44 U/ml 113 U/ml 67.4 U/ml
PR3-ANCA (after therapy) Negative 11 U/ml (4 mo) 6.3 U/ml (9 mo) 85.1 U/ml (5 mo)
Renal pathology MPGN MPGN MPGN Not performed
Treatment Shunt removal antibiotics Shunt removal, antibiotics PSL, mPSL pulse Shunt replacement antibiotics, PSL Shunt removal, antibiotics
Outcome Improve Improve Improve Improve
ANCA, antineutrophil cytoplasmic antibody; C3, complement component 3; C4, complement component 4; CH50, 50% hemolytic unit of component; MPGN, membranoproliferative
glomerulonephritis; mPSL, methylprednisolone; PR3, proteinase 3; PSL, prednisolone; VA, ventriculoatrial.
H Ono et al.: Shunt Nephritis With Positive PR3-ANCA NEPHROLOGY ROUNDSpreviously published case reports and our case of shunt
nephritis with positive PR3-ANCA are shown in
Table 2.16–18 Earlier reports showed that PR3-ANCA
returned to normal after treatment.
There remains much unknown about the precise
relationship between ANCA formation and vasculitis.
Previous studies revealed the relationship between
ANCA-related diseases and infection.19–21 Recent
studies have shown that neutrophil exudate traps may
play an important role with regard to ANCA levels and
tissue injury. Neutrophil exudate traps are nuclear-
derived chromatin fibers released from activated
neutrophil and contain PR3. Neutrophil exudate traps
can not only be a cause but also be a result of inflam-
mation.22 PR3-ANCA stimulates neutrophil exudate trap
secretion, and on the other hand, bacterial PR3 enhances
antibody production against PR3. This malignant cycle
is considered as one of the pathogeneses underlying
ANCA-related vasculitis or glomerulonephritis.13
PR3-ANCA levels in our patient remain high and have
not changed over 3 months after resolution of clinical
signs and symptoms. A previous single-center study
indicated that patients who showed positive c-ANCA/
PR3-ANCA without sufficient clinical or other evidence
of a systemic vasculitis had a small risk of developing
vasculitis later (Table 3).23 It is unclear whether or
not an elevated PR3-ANCA is related to the pathophys-
iology in this case, and we will carefully observe the
patient’s clinical course in the future.Table 3. Teaching points
 Shunt nephritis is a rare but important form of infection-related, immune complex-
mediated glomerulonephritis
 Mostly occurred in patients with chronically infected ventriculoatrial shunts
 The diagnosis of shunt nephritis is challenging
 Early diagnosis and treatment initiation with antibiotics and shunt removal is a key to
the successful management
Kidney International Reports (2017) 2, 774–778CONCLUSION
We successfully treated a patient with shunt nephritis
with antibiotic treatment and shunt removal. Hema-
turia, proteinuria, and progressive kidney dysfunction
all improved. It is unclear why PR3-ANCA becomes
positive in conditions related to chronic infection, and
it will be necessary to follow the PR3-ANCA titer in
this case. Physicians should be aware of the risks of
infection-related glomerulonephritis in patients with
VA shunts as early diagnosis and treatment initiation
with antibiotics and shunt removal is a key to the
successful management.
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